search
Back to results

The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne

Primary Purpose

Acne, Inflammation

Status
Unknown status
Phase
Phase 2
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Doxycycline
Sponsored by
Shahid Beheshti University of Medical Sciences
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acne

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Acne

Exclusion Criteria:

  • Pregnancy

Sites / Locations

  • Skin Research Center, Shaheed Beheshti Medical UniversityRecruiting

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
October 16, 2006
Last Updated
January 22, 2008
Sponsor
Shahid Beheshti University of Medical Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT00388778
Brief Title
The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne
Official Title
The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne
Study Type
Interventional

2. Study Status

Record Verification Date
January 2008
Overall Recruitment Status
Unknown status
Study Start Date
October 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
October 2006 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Shahid Beheshti University of Medical Sciences

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acne, Inflammation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Doxycycline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Acne Exclusion Criteria: Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Parviz Toossi, M.D.
Phone
98-21-22744392
Email
src@sbmu.ac.ir
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Parviz Toossi, M.D.
Organizational Affiliation
Shahid Beheshti University of Medical Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Skin Research Center, Shaheed Beheshti Medical University
City
Tehran
ZIP/Postal Code
19899
Country
Iran, Islamic Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Parviz Toossi, M.D.
Phone
98-21-22744392
Email
src@sbmu.ac.ir
First Name & Middle Initial & Last Name & Degree
Parviz Toossi, M.D.
First Name & Middle Initial & Last Name & Degree
Nahid Mohtasham, MD

12. IPD Sharing Statement

Learn more about this trial

The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne

We'll reach out to this number within 24 hrs